Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a simple IV drug shorten labor after water breaks?

NCT ID NCT07517796

First seen Apr 15, 2026 · Last updated Jun 21, 2026 · Updated 10 times

Summary

This study tests whether giving the drug papaverine through an IV can help women whose water has broken (but labor hasn't started yet) deliver faster. About 110 pregnant women at term will receive either papaverine or a placebo 12 hours after their water breaks. The goal is to see if the drug reduces the time from water breaking to delivery and improves outcomes for both mother and baby.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREMATURE RUPTURE OF MEMBRANES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Galilee Medical Center

    RECRUITING

    Nahariya, Israel, Israel

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

papaverine

What this could lead to

If it works, this could offer a simple, low-cost way to shorten labor after water breaks at term, potentially reducing infection risk and the need for cesarean delivery.

What could go wrong

This is a small, early-phase trial with only 110 participants, so results may not apply widely. Papaverine may not speed up labor more than placebo, and there is a risk of side effects like low blood pressure or allergic reactions.

Conditions

The condition(s) this trial relates to.

Fetal Membranes, Premature Rupture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.